FR2889948A1 - Composition cosmetique destinee a corriger, maintenir et ameliorer l'hydratation de la peau - Google Patents
Composition cosmetique destinee a corriger, maintenir et ameliorer l'hydratation de la peau Download PDFInfo
- Publication number
- FR2889948A1 FR2889948A1 FR0508795A FR0508795A FR2889948A1 FR 2889948 A1 FR2889948 A1 FR 2889948A1 FR 0508795 A FR0508795 A FR 0508795A FR 0508795 A FR0508795 A FR 0508795A FR 2889948 A1 FR2889948 A1 FR 2889948A1
- Authority
- FR
- France
- Prior art keywords
- skin
- vitamin
- cosmetic
- niacinamide
- seed extract
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- DFPAKSUCGFBDDF-UHFFFAOYSA-N nicotinic acid amide Natural products NC(=O)C1=CC=CN=C1 DFPAKSUCGFBDDF-UHFFFAOYSA-N 0.000 title claims abstract description 22
- 239000000203 mixture Substances 0.000 title claims abstract description 19
- 239000002537 cosmetic Substances 0.000 title claims abstract description 16
- PVNIIMVLHYAWGP-UHFFFAOYSA-N Niacin Chemical compound OC(=O)C1=CC=CN=C1 PVNIIMVLHYAWGP-UHFFFAOYSA-N 0.000 title claims abstract description 9
- 229930003537 Vitamin B3 Natural products 0.000 title claims abstract description 9
- 229940011403 apple seed extract Drugs 0.000 title claims abstract description 9
- 229960003512 nicotinic acid Drugs 0.000 title claims abstract description 9
- 235000019160 vitamin B3 Nutrition 0.000 title claims abstract description 9
- 239000011708 vitamin B3 Substances 0.000 title claims abstract description 9
- 239000011570 nicotinamide Substances 0.000 claims abstract description 17
- 229960003966 nicotinamide Drugs 0.000 claims abstract description 17
- 235000005152 nicotinamide Nutrition 0.000 claims abstract description 16
- 235000011430 Malus pumila Nutrition 0.000 claims abstract description 13
- 235000015103 Malus silvestris Nutrition 0.000 claims abstract description 13
- 244000141359 Malus pumila Species 0.000 claims abstract description 12
- 210000003491 skin Anatomy 0.000 claims description 24
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 claims description 15
- 230000036571 hydration Effects 0.000 claims description 15
- 238000006703 hydration reaction Methods 0.000 claims description 15
- 210000002615 epidermis Anatomy 0.000 claims description 14
- 239000000284 extract Substances 0.000 claims description 11
- 241000220324 Pyrus Species 0.000 claims description 6
- 239000004480 active ingredient Substances 0.000 claims description 6
- 235000011187 glycerol Nutrition 0.000 claims description 6
- 229920005862 polyol Polymers 0.000 claims description 6
- 150000003077 polyols Chemical class 0.000 claims description 6
- TVXBFESIOXBWNM-UHFFFAOYSA-N Xylitol Natural products OCCC(O)C(O)C(O)CCO TVXBFESIOXBWNM-UHFFFAOYSA-N 0.000 claims description 4
- HEBKCHPVOIAQTA-UHFFFAOYSA-N meso ribitol Natural products OCC(O)C(O)C(O)CO HEBKCHPVOIAQTA-UHFFFAOYSA-N 0.000 claims description 4
- 239000000419 plant extract Substances 0.000 claims description 4
- 239000000811 xylitol Substances 0.000 claims description 4
- HEBKCHPVOIAQTA-SCDXWVJYSA-N xylitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)CO HEBKCHPVOIAQTA-SCDXWVJYSA-N 0.000 claims description 4
- 235000010447 xylitol Nutrition 0.000 claims description 4
- 229960002675 xylitol Drugs 0.000 claims description 4
- FBPFZTCFMRRESA-FSIIMWSLSA-N D-Glucitol Natural products OC[C@H](O)[C@H](O)[C@@H](O)[C@H](O)CO FBPFZTCFMRRESA-FSIIMWSLSA-N 0.000 claims description 3
- FBPFZTCFMRRESA-JGWLITMVSA-N D-glucitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-JGWLITMVSA-N 0.000 claims description 3
- 238000000034 method Methods 0.000 claims description 3
- 239000000600 sorbitol Substances 0.000 claims description 3
- 235000010356 sorbitol Nutrition 0.000 claims description 3
- 229930003935 flavonoid Natural products 0.000 claims description 2
- 235000017173 flavonoids Nutrition 0.000 claims description 2
- 150000002215 flavonoids Chemical class 0.000 claims description 2
- 150000003817 isoflavonoid derivatives Chemical class 0.000 claims description 2
- 238000002360 preparation method Methods 0.000 claims description 2
- 230000008569 process Effects 0.000 claims description 2
- 229930013032 isoflavonoid Natural products 0.000 claims 1
- 235000012891 isoflavonoids Nutrition 0.000 claims 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 28
- 102000010637 Aquaporins Human genes 0.000 description 8
- 230000000694 effects Effects 0.000 description 8
- 108090000991 Aquaporin 3 Proteins 0.000 description 7
- 108010063290 Aquaporins Proteins 0.000 description 7
- 230000009471 action Effects 0.000 description 7
- 239000006071 cream Substances 0.000 description 7
- 230000003020 moisturizing effect Effects 0.000 description 7
- 210000002510 keratinocyte Anatomy 0.000 description 6
- 239000010410 layer Substances 0.000 description 6
- 230000037067 skin hydration Effects 0.000 description 6
- 102100037332 Aquaporin-3 Human genes 0.000 description 5
- 210000000434 stratum corneum Anatomy 0.000 description 5
- 238000012360 testing method Methods 0.000 description 5
- 230000000887 hydrating effect Effects 0.000 description 4
- 239000006210 lotion Substances 0.000 description 4
- 230000004888 barrier function Effects 0.000 description 3
- 150000002632 lipids Chemical class 0.000 description 3
- 238000005259 measurement Methods 0.000 description 3
- 239000003755 preservative agent Substances 0.000 description 3
- 108090001004 Aquaporin 1 Proteins 0.000 description 2
- 102000004363 Aquaporin 3 Human genes 0.000 description 2
- 241000196324 Embryophyta Species 0.000 description 2
- 102000004190 Enzymes Human genes 0.000 description 2
- 108090000790 Enzymes Proteins 0.000 description 2
- 229910021380 Manganese Chloride Inorganic materials 0.000 description 2
- 230000032683 aging Effects 0.000 description 2
- 230000003712 anti-aging effect Effects 0.000 description 2
- 230000015572 biosynthetic process Effects 0.000 description 2
- RYYVLZVUVIJVGH-UHFFFAOYSA-N caffeine Chemical compound CN1C(=O)N(C)C(=O)C2=C1N=CN2C RYYVLZVUVIJVGH-UHFFFAOYSA-N 0.000 description 2
- 239000000969 carrier Substances 0.000 description 2
- 210000000170 cell membrane Anatomy 0.000 description 2
- 230000001413 cellular effect Effects 0.000 description 2
- 229940106189 ceramide Drugs 0.000 description 2
- 150000001783 ceramides Chemical class 0.000 description 2
- 229960000541 cetyl alcohol Drugs 0.000 description 2
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 2
- 239000000839 emulsion Substances 0.000 description 2
- 239000000499 gel Substances 0.000 description 2
- 229940075529 glyceryl stearate Drugs 0.000 description 2
- 230000006872 improvement Effects 0.000 description 2
- 235000002867 manganese chloride Nutrition 0.000 description 2
- 239000011565 manganese chloride Substances 0.000 description 2
- 229940099607 manganese chloride Drugs 0.000 description 2
- 235000013336 milk Nutrition 0.000 description 2
- 239000008267 milk Substances 0.000 description 2
- 210000004080 milk Anatomy 0.000 description 2
- DNIAPMSPPWPWGF-UHFFFAOYSA-N monopropylene glycol Natural products CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 description 2
- BXWNKGSJHAJOGX-UHFFFAOYSA-N n-hexadecyl alcohol Natural products CCCCCCCCCCCCCCCCO BXWNKGSJHAJOGX-UHFFFAOYSA-N 0.000 description 2
- 239000000546 pharmaceutical excipient Substances 0.000 description 2
- 229940068196 placebo Drugs 0.000 description 2
- 239000000902 placebo Substances 0.000 description 2
- 230000003068 static effect Effects 0.000 description 2
- 238000003786 synthesis reaction Methods 0.000 description 2
- 230000001256 tonic effect Effects 0.000 description 2
- WWUZIQQURGPMPG-UHFFFAOYSA-N (-)-D-erythro-Sphingosine Natural products CCCCCCCCCCCCCC=CC(O)C(N)CO WWUZIQQURGPMPG-UHFFFAOYSA-N 0.000 description 1
- MTCFGRXMJLQNBG-REOHCLBHSA-N (2S)-2-Amino-3-hydroxypropansäure Chemical compound OC[C@H](N)C(O)=O MTCFGRXMJLQNBG-REOHCLBHSA-N 0.000 description 1
- KIUKXJAPPMFGSW-DNGZLQJQSA-N (2S,3S,4S,5R,6R)-6-[(2S,3R,4R,5S,6R)-3-Acetamido-2-[(2S,3S,4R,5R,6R)-6-[(2R,3R,4R,5S,6R)-3-acetamido-2,5-dihydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-2-carboxy-4,5-dihydroxyoxan-3-yl]oxy-5-hydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-3,4,5-trihydroxyoxane-2-carboxylic acid Chemical compound CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@H](O[C@H]2[C@@H]([C@@H](O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@H](O3)C(O)=O)O)[C@H](O)[C@@H](CO)O2)NC(C)=O)[C@@H](C(O)=O)O1 KIUKXJAPPMFGSW-DNGZLQJQSA-N 0.000 description 1
- OIALAIQRYISUEV-UHFFFAOYSA-N 2-[2-[2-[2-[2-[2-[2-[2-[2-[2-[2-[2-[2-[2-[2-[2-[2-[2-[2-[2-[2-[2-[2-[2-[2-[2-[2-[2-[2-[2-[2-[2-[2-[2-[2-[2-[2-[2-[2-[2-[2-[2-[2-[2-[2-[2-[2-[2-[2-(2-hydroxyethoxy)ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]e Chemical compound CCCCCCCCCCCCCCCCCC(=O)OCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCO OIALAIQRYISUEV-UHFFFAOYSA-N 0.000 description 1
- 125000000954 2-hydroxyethyl group Chemical group [H]C([*])([H])C([H])([H])O[H] 0.000 description 1
- 102000004888 Aquaporin 1 Human genes 0.000 description 1
- 108050006914 Aquaporin 9 Proteins 0.000 description 1
- 102100023771 Aquaporin-1 Human genes 0.000 description 1
- 102100029406 Aquaporin-7 Human genes 0.000 description 1
- 102100029464 Aquaporin-9 Human genes 0.000 description 1
- -1 Ascorbyl Magnesium Phosphate Chemical compound 0.000 description 1
- 108010011485 Aspartame Proteins 0.000 description 1
- 108091006146 Channels Proteins 0.000 description 1
- SRBFZHDQGSBBOR-IOVATXLUSA-N D-xylopyranose Chemical compound O[C@@H]1COC(O)[C@H](O)[C@H]1O SRBFZHDQGSBBOR-IOVATXLUSA-N 0.000 description 1
- 101000771402 Homo sapiens Aquaporin-7 Proteins 0.000 description 1
- 101000771413 Homo sapiens Aquaporin-9 Proteins 0.000 description 1
- 241000138806 Impages Species 0.000 description 1
- LPHGQDQBBGAPDZ-UHFFFAOYSA-N Isocaffeine Natural products CN1C(=O)N(C)C(=O)C2=C1N(C)C=N2 LPHGQDQBBGAPDZ-UHFFFAOYSA-N 0.000 description 1
- 241000220225 Malus Species 0.000 description 1
- GLFNIEUTAYBVOC-UHFFFAOYSA-L Manganese chloride Chemical compound Cl[Mn]Cl GLFNIEUTAYBVOC-UHFFFAOYSA-L 0.000 description 1
- 108010052285 Membrane Proteins Proteins 0.000 description 1
- 241001465754 Metazoa Species 0.000 description 1
- 241000699670 Mus sp. Species 0.000 description 1
- VYGQUTWHTHXGQB-UHFFFAOYSA-N Retinol hexadecanoate Natural products CCCCCCCCCCCCCCCC(=O)OCC=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C VYGQUTWHTHXGQB-UHFFFAOYSA-N 0.000 description 1
- MTCFGRXMJLQNBG-UHFFFAOYSA-N Serine Natural products OCC(N)C(O)=O MTCFGRXMJLQNBG-UHFFFAOYSA-N 0.000 description 1
- 102000015785 Serine C-Palmitoyltransferase Human genes 0.000 description 1
- 108010024814 Serine C-palmitoyltransferase Proteins 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 239000013543 active substance Substances 0.000 description 1
- 239000000605 aspartame Substances 0.000 description 1
- 235000010357 aspartame Nutrition 0.000 description 1
- IAOZJIPTCAWIRG-QWRGUYRKSA-N aspartame Chemical compound OC(=O)C[C@H](N)C(=O)N[C@H](C(=O)OC)CC1=CC=CC=C1 IAOZJIPTCAWIRG-QWRGUYRKSA-N 0.000 description 1
- 229960003438 aspartame Drugs 0.000 description 1
- SRBFZHDQGSBBOR-UHFFFAOYSA-N beta-D-Pyranose-Lyxose Natural products OC1COC(O)C(O)C1O SRBFZHDQGSBBOR-UHFFFAOYSA-N 0.000 description 1
- 230000037396 body weight Effects 0.000 description 1
- 229960001948 caffeine Drugs 0.000 description 1
- VJEONQKOZGKCAK-UHFFFAOYSA-N caffeine Natural products CN1C(=O)N(C)C(=O)C2=C1C=CN2C VJEONQKOZGKCAK-UHFFFAOYSA-N 0.000 description 1
- 239000004227 calcium gluconate Substances 0.000 description 1
- 229960004494 calcium gluconate Drugs 0.000 description 1
- 235000013927 calcium gluconate Nutrition 0.000 description 1
- NEEHYRZPVYRGPP-UHFFFAOYSA-L calcium;2,3,4,5,6-pentahydroxyhexanoate Chemical compound [Ca+2].OCC(O)C(O)C(O)C(O)C([O-])=O.OCC(O)C(O)C(O)C(O)C([O-])=O NEEHYRZPVYRGPP-UHFFFAOYSA-L 0.000 description 1
- 210000004027 cell Anatomy 0.000 description 1
- 239000004568 cement Substances 0.000 description 1
- 235000012000 cholesterol Nutrition 0.000 description 1
- 150000001840 cholesterol esters Chemical class 0.000 description 1
- 238000012937 correction Methods 0.000 description 1
- 210000000805 cytoplasm Anatomy 0.000 description 1
- 238000012303 cytoplasmic staining Methods 0.000 description 1
- ZAKOWWREFLAJOT-UHFFFAOYSA-N d-alpha-Tocopheryl acetate Natural products CC(=O)OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C ZAKOWWREFLAJOT-UHFFFAOYSA-N 0.000 description 1
- 230000003247 decreasing effect Effects 0.000 description 1
- 230000002950 deficient Effects 0.000 description 1
- 230000006735 deficit Effects 0.000 description 1
- 230000018044 dehydration Effects 0.000 description 1
- 238000006297 dehydration reaction Methods 0.000 description 1
- 210000004207 dermis Anatomy 0.000 description 1
- 235000014113 dietary fatty acids Nutrition 0.000 description 1
- 230000004069 differentiation Effects 0.000 description 1
- 150000002148 esters Chemical class 0.000 description 1
- 239000000194 fatty acid Substances 0.000 description 1
- 229930195729 fatty acid Natural products 0.000 description 1
- 150000004665 fatty acids Chemical class 0.000 description 1
- 230000001605 fetal effect Effects 0.000 description 1
- 230000004907 flux Effects 0.000 description 1
- 239000003205 fragrance Substances 0.000 description 1
- 229940068517 fruit extracts Drugs 0.000 description 1
- 229920002674 hyaluronan Polymers 0.000 description 1
- 229960003160 hyaluronic acid Drugs 0.000 description 1
- 238000003125 immunofluorescent labeling Methods 0.000 description 1
- 238000000338 in vitro Methods 0.000 description 1
- 238000001727 in vivo Methods 0.000 description 1
- CJWQYWQDLBZGPD-UHFFFAOYSA-N isoflavone Natural products C1=C(OC)C(OC)=CC(OC)=C1C1=COC2=C(C=CC(C)(C)O3)C3=C(OC)C=C2C1=O CJWQYWQDLBZGPD-UHFFFAOYSA-N 0.000 description 1
- 150000002515 isoflavone derivatives Chemical class 0.000 description 1
- 235000008696 isoflavones Nutrition 0.000 description 1
- 229930013035 isoflavonoid derivative Natural products 0.000 description 1
- 125000001449 isopropyl group Chemical group [H]C([H])([H])C([H])(*)C([H])([H])[H] 0.000 description 1
- 230000000670 limiting effect Effects 0.000 description 1
- 210000005229 liver cell Anatomy 0.000 description 1
- 229910052749 magnesium Inorganic materials 0.000 description 1
- 239000011777 magnesium Substances 0.000 description 1
- 229960001983 magnesium aspartate Drugs 0.000 description 1
- 239000004137 magnesium phosphate Substances 0.000 description 1
- 229960002261 magnesium phosphate Drugs 0.000 description 1
- 229910000157 magnesium phosphate Inorganic materials 0.000 description 1
- 235000010994 magnesium phosphates Nutrition 0.000 description 1
- 229940091250 magnesium supplement Drugs 0.000 description 1
- RXMQCXCANMAVIO-CEOVSRFSSA-L magnesium;(2s)-2-amino-4-hydroxy-4-oxobutanoate Chemical compound [H+].[H+].[Mg+2].[O-]C(=O)[C@@H](N)CC([O-])=O.[O-]C(=O)[C@@H](N)CC([O-])=O RXMQCXCANMAVIO-CEOVSRFSSA-L 0.000 description 1
- 238000012423 maintenance Methods 0.000 description 1
- 239000012528 membrane Substances 0.000 description 1
- 108020004999 messenger RNA Proteins 0.000 description 1
- 230000004060 metabolic process Effects 0.000 description 1
- 238000012544 monitoring process Methods 0.000 description 1
- 230000008723 osmotic stress Effects 0.000 description 1
- MNBKLUUYKPBKDU-BBECNAHFSA-N palmitoyl-CoA Chemical compound O[C@@H]1[C@H](OP(O)(O)=O)[C@@H](COP(O)(=O)OP(O)(=O)OCC(C)(C)[C@@H](O)C(=O)NCCC(=O)NCCSC(=O)CCCCCCCCCCCCCCC)O[C@H]1N1C2=NC=NC(N)=C2N=C1 MNBKLUUYKPBKDU-BBECNAHFSA-N 0.000 description 1
- 230000035699 permeability Effects 0.000 description 1
- 230000002688 persistence Effects 0.000 description 1
- 230000009993 protective function Effects 0.000 description 1
- 239000011241 protective layer Substances 0.000 description 1
- 230000009467 reduction Effects 0.000 description 1
- 230000001105 regulatory effect Effects 0.000 description 1
- 230000008439 repair process Effects 0.000 description 1
- 230000000717 retained effect Effects 0.000 description 1
- 229940108325 retinyl palmitate Drugs 0.000 description 1
- VYGQUTWHTHXGQB-FFHKNEKCSA-N retinyl palmitate Natural products CCCCCCCCCCCCCCCC(=O)OC\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C VYGQUTWHTHXGQB-FFHKNEKCSA-N 0.000 description 1
- 235000019172 retinyl palmitate Nutrition 0.000 description 1
- 239000011769 retinyl palmitate Substances 0.000 description 1
- 239000002356 single layer Substances 0.000 description 1
- 229930188627 soysaponin Natural products 0.000 description 1
- WWUZIQQURGPMPG-KRWOKUGFSA-N sphingosine Chemical compound CCCCCCCCCCCCC\C=C\[C@@H](O)[C@@H](N)CO WWUZIQQURGPMPG-KRWOKUGFSA-N 0.000 description 1
- 238000005728 strengthening Methods 0.000 description 1
- 230000035882 stress Effects 0.000 description 1
- 235000000346 sugar Nutrition 0.000 description 1
- 150000008163 sugars Chemical class 0.000 description 1
- 230000035900 sweating Effects 0.000 description 1
- 208000024891 symptom Diseases 0.000 description 1
- 229940042585 tocopherol acetate Drugs 0.000 description 1
- 230000000699 topical effect Effects 0.000 description 1
- 238000012546 transfer Methods 0.000 description 1
- 229940099259 vaseline Drugs 0.000 description 1
- 235000013311 vegetables Nutrition 0.000 description 1
- 229940088594 vitamin Drugs 0.000 description 1
- 229930003231 vitamin Natural products 0.000 description 1
- 235000013343 vitamin Nutrition 0.000 description 1
- 239000011782 vitamin Substances 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/67—Vitamins
- A61K8/673—Vitamin B group
- A61K8/675—Vitamin B3 or vitamin B3 active, e.g. nicotinamide, nicotinic acid, nicotinyl aldehyde
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
- A61K8/97—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
- A61K8/9783—Angiosperms [Magnoliophyta]
- A61K8/9789—Magnoliopsida [dicotyledons]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
- A61Q19/007—Preparations for dry skin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
- A61Q19/08—Anti-ageing preparations
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Birds (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Biotechnology (AREA)
- Botany (AREA)
- Microbiology (AREA)
- Mycology (AREA)
- Dermatology (AREA)
- Cosmetics (AREA)
Abstract
Description
Claims (8)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FR0508795A FR2889948B1 (fr) | 2005-08-26 | 2005-08-26 | Composition cosmetique destinee a corriger, maintenir et ameliorer l'hydratation de la peau |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FR0508795A FR2889948B1 (fr) | 2005-08-26 | 2005-08-26 | Composition cosmetique destinee a corriger, maintenir et ameliorer l'hydratation de la peau |
Publications (2)
Publication Number | Publication Date |
---|---|
FR2889948A1 true FR2889948A1 (fr) | 2007-03-02 |
FR2889948B1 FR2889948B1 (fr) | 2008-04-04 |
Family
ID=36602417
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
FR0508795A Active FR2889948B1 (fr) | 2005-08-26 | 2005-08-26 | Composition cosmetique destinee a corriger, maintenir et ameliorer l'hydratation de la peau |
Country Status (1)
Country | Link |
---|---|
FR (1) | FR2889948B1 (fr) |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2009103618A1 (fr) * | 2008-02-18 | 2009-08-27 | Unilever Plc | Amélioration de l'humidification par le biais d'un cosmétique liquide contenant du niacinamide chauffé transféré sur la peau |
CN109956882A (zh) * | 2019-03-18 | 2019-07-02 | 安徽农业大学 | 一种泛酸钙的制备方法 |
Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6444647B1 (en) * | 1999-04-19 | 2002-09-03 | The Procter & Gamble Company | Skin care compositions containing combination of skin care actives |
EP1459736A1 (fr) * | 2003-03-14 | 2004-09-22 | The Procter & Gamble Company | Composition de soins de la peau pour améliorer la fonction de barrière de la peau |
WO2005044219A1 (fr) * | 2003-10-31 | 2005-05-19 | The Procter & Gamble Company | Composition cosmetique a base d'acide deshydroacetique et d'agents cosmetiques |
WO2006020164A1 (fr) * | 2004-07-23 | 2006-02-23 | The Procter & Gamble Company | Composition d’un soin cutané contenant un flavonoïde et de la vitamine b3 |
-
2005
- 2005-08-26 FR FR0508795A patent/FR2889948B1/fr active Active
Patent Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6444647B1 (en) * | 1999-04-19 | 2002-09-03 | The Procter & Gamble Company | Skin care compositions containing combination of skin care actives |
EP1459736A1 (fr) * | 2003-03-14 | 2004-09-22 | The Procter & Gamble Company | Composition de soins de la peau pour améliorer la fonction de barrière de la peau |
WO2005044219A1 (fr) * | 2003-10-31 | 2005-05-19 | The Procter & Gamble Company | Composition cosmetique a base d'acide deshydroacetique et d'agents cosmetiques |
WO2006020164A1 (fr) * | 2004-07-23 | 2006-02-23 | The Procter & Gamble Company | Composition d’un soin cutané contenant un flavonoïde et de la vitamine b3 |
Non-Patent Citations (3)
Title |
---|
HERBAL LUXURIES NATURAL SKIN CARE-PRODUCT CATALOG-WINTER 2005-SPRING 2006, October 2005 (2005-10-01) - April 2006 (2006-04-01), XP002387996, Retrieved from the Internet <URL:http://www.herballuxuries.com/herbal%20luxuries%20catalog%202006-2.pdf> [retrieved on 20060629] * |
HERBAL LUXURIES: "Ageless faces Anti Aging Advanced Night Facial Moisturizer", October 2005 (2005-10-01) - April 2006 (2006-04-01), XP002387995, Retrieved from the Internet <URL:http://www.solveitskincare.com/store/products/antiaging-moisturizer.html> [retrieved on 20060629] * |
HERBAL LUXURIES: "Skincare products Ingredients", ANTI AGING SKIN CARE PRODUCTS, October 2005 (2005-10-01) - April 2006 (2006-04-01), XP002387994, Retrieved from the Internet <URL:http://www.solveitskincare.com/skincare-ingredients.asp> [retrieved on 20060629] * |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2009103618A1 (fr) * | 2008-02-18 | 2009-08-27 | Unilever Plc | Amélioration de l'humidification par le biais d'un cosmétique liquide contenant du niacinamide chauffé transféré sur la peau |
CN109956882A (zh) * | 2019-03-18 | 2019-07-02 | 安徽农业大学 | 一种泛酸钙的制备方法 |
Also Published As
Publication number | Publication date |
---|---|
FR2889948B1 (fr) | 2008-04-04 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
WO2008000974A2 (fr) | Composition cosmetique a base d'acide gras polyinsatures et ses utilisations | |
CA2566905A1 (fr) | Association d'extraits vegetaux a base de groseille maquereau, d'orchidee noire et de tulipe noire et composition topique comprenant l'association de ces extraits vegetaux | |
EP2691074A1 (fr) | Composition a base de camellia japonica et polygonum hydropiper pour protection de la peau | |
EP0946138B1 (fr) | Utilisation d'un extrait de potentilla erecta dans le domaine de la cosmetique et de la pharmacie | |
CN115105453A (zh) | 一种具有抗菌、消炎和修复功能的护肤品及其制备方法 | |
WO2017178751A1 (fr) | Utilisation cosmétique d'un extrait de khaya senegalensis | |
FR2813018A1 (fr) | Compositions cosmetiques renfermant au moins un compose stimulant la neosynthese des laminines, et/ou de l'integrine alpha-2 beta-1 et/ou du collagene iv de la jonction dermo- epidermique | |
EP3052199A1 (fr) | Utilisation d'une composition huileuse contenant un extrait d'hemerocalle pour ameliorer la fermete de la peau | |
FR3110411A1 (fr) | Complexe à base de rétinol, de tripeptide-1 et de lactate de menthyle et ses applications en cosmétique | |
FR2889948A1 (fr) | Composition cosmetique destinee a corriger, maintenir et ameliorer l'hydratation de la peau | |
FR2948877A1 (fr) | Composition pour la protection et la regeneration de la peau | |
FR3004347A1 (fr) | Composition cosmetique comprenant une huile essentielle de sauge et son utilisation | |
FR2977158A1 (fr) | Utilisation d'huile essentielle de bursera graveolens | |
CN113181070A (zh) | 一种具有祛皱抗衰作用的润肤霜及其制备方法 | |
EP2952174A1 (fr) | Compositions de soins de la peau | |
FR3102365A1 (fr) | Utilisation d’un extrait deLimonium vulgarepour hydrater la peau et améliorer la fonction barrière. | |
FR2960436A1 (fr) | Composition cosmetique - dermatologique comprenant au moins une huile essentielle et leur utilisation | |
FR3056106A1 (fr) | Utilisation cosmetique d’une composition comprenant une eau thermale en association avec au moins deux autres agents actifs pour l’amelioration de l’aspect general de la peau | |
FR2997854A1 (fr) | Utilisation d'un extrait de saba senegalensis dans une composition cosmetique anti-age | |
FR3034015A1 (fr) | Composition comprenant des fleurs sechees d'immortelle pour un usage cosmetique | |
WO2023186353A1 (fr) | Dextrines hyperbranchees pour leur utilisation topique pour la prevention ou le traitement d'au moins un symptome de l'inflammation cutanee | |
FR3021539A1 (fr) | Composition cosmetique et/ou dermatologique comprenant un extrait vegetal et un activateur de genes | |
FR3097763A1 (fr) | Utilisation d'un extrait d'Armérie maritime (Armeria maritima) pour hydrater la peau et améliorer la fonction barrière | |
FR2974511A1 (fr) | Composition cosmetique comprenant une huile essentielle de lavande et leur utilisation | |
FR2958545A1 (fr) | Utilisation cosmetique d'un extrait de coing |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
RN | Application for restoration | ||
FC | Decision of inpi director general to approve request for restoration | ||
PLFP | Fee payment |
Year of fee payment: 12 |
|
PLFP | Fee payment |
Year of fee payment: 13 |
|
PLFP | Fee payment |
Year of fee payment: 14 |
|
PLFP | Fee payment |
Year of fee payment: 15 |
|
PLFP | Fee payment |
Year of fee payment: 16 |
|
PLFP | Fee payment |
Year of fee payment: 17 |
|
PLFP | Fee payment |
Year of fee payment: 18 |
|
PLFP | Fee payment |
Year of fee payment: 19 |
|
AU | Other action affecting the ownership or exploitation of an industrial property right |
Effective date: 20231016 |
|
CL | Concession to grant licences |
Name of requester: NAOS, FR Effective date: 20231016 Name of requester: NAOS INSTITUTE OF LIFE SCIENCE, FR Effective date: 20231016 |